 |
|
|
Home
> Research & Development
Focused on metabolic diseases, dermatology and central nervous system disorders, DARA’s subsidiaries oversee the development of multiple candidate therapeutics. Most of this development effort is focused on small molecules from late preclinical development through phase 2a clinical trials.
Showing all current candidates in development, the pipeline provides an “at a glance” view of each candidate’s progression.
|
|
R&D Pipeline